Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival

Journal of Experimental Medicine

Volumn 210, Issue 1, 2013, Pages 157-172

  Luo, Jian ^a   Elwood, Fiona ^a   Britschgi, Markus ^a   Villeda, Saul ^a   Zhang, Hui ^a   Ding, Zhaoqing ^a   Zhu, Liyin ^b   Alabsi, Haitham ^a   Getachew, Ruth ^a   Narasimhan, Ramya ^a   Wabl, Rafael ^a   Fainberg, Nina ^a   James, Michelle L ^a   Wong, Gordon ^c   Relton, Jane ^c   Gambhir, Sanjiv S ^a   Pollard, Jeffrey W ^b   Wyss Coray, Tony ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BIOGEN   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; EXCITOTOXIN; INTERLEUKIN 34; KAINIC ACID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CELL INFILTRATION; CELL LINEAGE; CELL LOSS; CELL LYSATE; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXCITOTOXICITY; FOREBRAIN; GLIOSIS; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; MAZE TEST; MEMORY; MICROGLIA; MOUSE; NERVE CELL LESION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARABIOSIS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TARGET CELL; WESTERN BLOTTING; WILD TYPE;

EID: 84874539371     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120412     Document Type: Article

References (77)

1. Adlard, P.A., V.M. Perreau, V. Pop, and C.W. Cotman. 2005. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 25:4217-4221. http://dx.doi.org/10.1523/JNEUROSCI.0496-05.2005
2. Ajami, B., J.L. Bennett, C. Krieger, W. Tetzlaff, and F.M. Rossi. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10:1538-1543. http://dx.doi.org/10.1038/nn2014
3. Berezovskaya, O., D. Maysinger, and S. Fedoroff. 1995. The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int. J. Dev. Neurosci. 13:285-299. http://dx.doi.org/10.1016/0736-5748(95)00013-7
4. Berezovskaya, O., D. Maysinger, and S. Fedoroff. 1996. Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathol. 92:479-486. http://dx.doi.org/10.1007/s004010050550
5. Boissonneault, V., M. Filali, M. Lessard, J. Relton, G. Wong, and S. Rivest. 2009. Powerful beneficial effects of macrophage colonystimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain. 132:1078-1092. http://dx.doi.org/10.1093/brain/awn331
6. Britschgi, M., K. Rufibach, S.L. Huang, C.M. Clark, J.A. Kaye, G. Li, E.R. Peskind, J.F. Quinn, D.R. Galasko, and T. Wyss-Coray. 2011. Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol. Cell. Proteomics. 10:M111: 008862.
7. Burnett, S.H., E.J. Kershen, J. Zhang, L. Zeng, S.C. Straley, A.M. Kaplan, and D.A. Cohen. 2004. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 75:612-623. http://dx.doi.org/10.1189/jlb.0903442
8. Casals-Casas, C., E. Alvarez, M. Serra, C. de la Torre, C. Farrera, E. Sánchez-Tilló, C. Caelles, J. Lloberas, and A. Celada. 2009. CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation. Eur. J. Immunol. 39:1902-1913. http://dx.doi.org/10.1002/eji.200839037
9. Chihara, T., S. Suzu, R. Hassan, N. Chutiwitoonchai, M. Hiyoshi, K. Motoyoshi, F. Kimura, and S. Okada. 2010. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 17:1917-1927. http://dx.doi.org/10.1038/cdd.2010.60
10. Chitu, V., and E.R. Stanley. 2006. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18:39-48. http://dx.doi.org/10.1016/j.coi.2005.11.006
11. Conway, J.G., B. McDonald, J. Parham, B. Keith, D.W. Rusnak, E. Shaw, M. Jansen, P. Lin, A. Payne, R.M. Crosby, et al. 2005. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc. Natl. Acad. Sci. USA. 102:16078- 16083. http://dx.doi.org/10.1073/pnas.0502000102
12. Dai, X.M., G.R. Ryan, A.J. Hapel, M.G. Dominguez, R.G. Russell, S. Kapp, V. Sylvestre, and E.R. Stanley. 2002. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 99:111-120. http://dx.doi.org/10.1182/blood.V99.1.111
13. Deng, L., J.F. Zhou, R.S. Sellers, J.F. Li, A.V. Nguyen, Y. Wang, A. Orlofsky, Q. Liu, D.A. Hume, J.W. Pollard, et al. 2010. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am. J. Pathol. 176:952-967. http://dx.doi.org/10.2353/ajpath.2010.090622
14. Dommergues, M.A., F. Plaisant, C. Verney, and P. Gressens. 2003. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience. 121:619-628. http://dx.doi.org/10.1016/S0306-4522(03)00558-X
15. Douglass, T.G., L. Driggers, J.G. Zhang, N. Hoa, C. Delgado, C.C. Williams, Q. Dan, R. Sanchez, E.W. Jeffes, H.T. Wepsic, et al. 2008. Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies. Int. Immunopharmacol. 8:1354- 1376. http://dx.doi.org/10.1016/j.intimp.2008.04.016
16. Du Yan, S., H. Zhu, J. Fu, S.F. Yan, A. Roher, W.W. Tourtellotte, T. Rajavashisth, X. Chen, G.C. Godman, D. Stern, and A.M. Schmidt. 1997. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:5296-5301. http://dx.doi.org/10.1073/pnas.94.10.5296
17. Erblich, B., L. Zhu, A.M. Etgen, K. Dobrenis, and J.W. Pollard. 2011. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS ONE. 6:e26317. http://dx.doi.org/10.1371/journal.pone.0026317
18. Fan, G., C. Beard, R.Z. Chen, G. Csankovszki, Y. Sun, M. Siniaia, D. Biniszkiewicz, B. Bates, P.P. Lee, R. Kuhn, et al. 2001. DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J. Neurosci. 21:788-797.
19. Ferrer, I., R. Blanco, M. Carmona, B. Puig, I. Domínguez, and F. Viñals. 2002. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat. Acta Neuropathol. 103:391-407. http://dx.doi.org/10.1007/s00401-001-0481-9
20. Garceau, V., J. Smith, I.R. Paton, M. Davey, M.A. Fares, D.P. Sester, D.W. Burt, and D.A. Hume. 2010. Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products. J. Leukoc. Biol. 87:753-764. http://dx.doi.org/10.1189/jlb.0909624
21. Ginhoux, F., M. Greter, M. Leboeuf, S. Nandi, P. See, S. Gokhan, M.F. Mehler, S.J. Conway, L.G. Ng, E.R. Stanley, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 330:841-845. http://dx.doi.org/10.1126/science.1194637
22. Gowing, G., M. Lalancette-Hébert, J.N. Audet, F. Dequen, and J.P. Julien. 2009. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase. Exp. Neurol. 220:267-275. http://dx.doi.org/10.1016/j.expneurol.2009.08.021
23. Hamilton, J.A. 1997. CSF-1 signal transduction. J. Leukoc. Biol. 62: 145-155.
24. Hamilton, J.A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8:533-544. http://dx.doi.org/10.1038/nri2356
25. Hamilton, J.A., and A. Achuthan. 2012. Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol. http://dx.doi.org/10.1016/j.it.2012.08.006
26. Hume, D.A., and K.P. MacDonald. 2012. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood. 119:1810-1820. http://dx.doi.org/10.1182/blood-2011-09-379214
27. Imai, Y., and S. Kohsaka. 2002. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia. 40:164-174. http://dx.doi.org/10.1002/glia.10149
28. Janumpalli, S., L.S. Butler, L.B. MacMillan, L.E. Limbird, and J.O. McNamara. 1998. A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine. J. Neurosci. 18:2004-2008.
29. Kandel, E.R. 2001. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 294:1030-1038. http://dx.doi.org/10.1126/science.1067020
30. Knowles, J.K., J. Rajadas, T.V. Nguyen, T. Yang, M.C. LeMieux, L. Vander Griend, C. Ishikawa, S.M. Massa, T. Wyss-Coray, and F.M. Longo. 2009. The p75 neurotrophin receptor promotes amyloid-beta(1-42)- induced neuritic dystrophy in vitro and in vivo. J. Neurosci. 29:10627- 10637. http://dx.doi.org/10.1523/JNEUROSCI.0620-09.2009
31. Li, J., K. Chen, L. Zhu, and J.W. Pollard. 2006. Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. Genesis. 44:328-335. http://dx.doi.org/10.1002/dvg.20219
32. Li, M., K. Pisalyaput, M. Galvan, and A.J. Tenner. 2004. Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity. J. Neurochem. 91:623-633. http://dx.doi.org/10.1111/j.1471-4159.2004.02765.x
33. Lin, A.H., J. Luo, L.H. Mondshein, P. ten Dijke, D. Vivien, C.H. Contag, and T. Wyss-Coray. 2005. Global analysis of Smad2/3-dependent TGFbeta signaling in living mice reveals prominent tissue-specific responses to injury. J. Immunol. 175:547-554.
34. Lin, H., E. Lee, K. Hestir, C. Leo, M. Huang, E. Bosch, R. Halenbeck, G. Wu, A. Zhou, D. Behrens, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science. 320:807-811. http://dx.doi.org/10.1126/science.1154370
35. Liu, H., C. Leo, X. Chen, B.R. Wong, L.T. Williams, H. Lin, and X. He. 2012. The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. Biochim. Biophys. Acta. 1824:938-945. http://dx.doi.org/10.1016/j.bbapap.2012.04.012
36. Lonze, B.E., and D.D. Ginty. 2002. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 35:605-623. http://dx.doi.org/10.1016/S0896-6273(02)00828-0
37. Luo, J., A.H. Lin, E. Masliah, and T. Wyss-Coray. 2006. Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc. Natl. Acad. Sci. USA. 103:18326-18331. http://dx.doi.org/10.1073/pnas.0605077103
38. Luo, J., P.P. Ho, M.S. Buckwalter, T. Hsu, L.Y. Lee, H. Zhang, D.K. Kim, S.J. Kim, S.S. Gambhir, L. Steinman, and T. Wyss-Coray. 2007. Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. J. Clin. Invest. 117:3306-3315. http://dx.doi.org/10.1172/JCI31763
39. Majumdar, A., D. Cruz, N. Asamoah, A. Buxbaum, I. Sohar, P. Lobel, and F.R. Maxfield. 2007. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell. 18:1490-1496. http://dx.doi.org/10.1091/mbc.E06-10-0975
40. Mattson, M.P. 2004. Pathways towards and away from Alzheimer's disease. Nature. 430:631-639. http://dx.doi.org/10.1038/nature02621
41. Maurer, M.H., W.R. Schäbitz, and A. Schneider. 2008. Old friends in new constellations-the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases. Curr. Med. Chem. 15:1407-1411. http://dx.doi.org/10.2174/092986708784567671
42. Michaelson, M.D., P.L. Bieri, M.F. Mehler, H. Xu, J.C. Arezzo, J.W. Pollard, and J.A. Kessler. 1996. CSF-1 deficiency in mice results in abnormal brain development. Development. 122:2661-2672.
43. Mizuno, T., Y. Doi, H. Mizoguchi, S. Jin, M. Noda, Y. Sonobe, H. Takeuchi, and A. Suzumura. 2011. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid- ? neurotoxicity. Am. J. Pathol. 179:2016-2027. http://dx.doi.org/10.1016/j.ajpath.2011.06.011
44. Murase, S., and Y. Hayashi. 1998. Expression pattern and neurotrophic role of the c-fms proto-oncogene M-CSF receptor in rodent Purkinje cells. J. Neurosci. 18:10481-10492.
45. Murphy, G.M. Jr., L. Yang, and B. Cordell. 1998. Macrophage colonystimulating factor augments beta-amyloid-induced interleukin-1, interleukin- 6, and nitric oxide production by microglial cells. J. Biol. Chem. 273:20967-20971. http://dx.doi.org/10.1074/jbc.273.33.20967
46. Murphy, G.M. Jr., F. Zhao, L. Yang, and B. Cordell. 2000. Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP (V717F) transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 157:895-904. http://dx.doi.org/10.1016/S0002-9440(10)64603-2
47. Muzumdar, M.D., B. Tasic, K. Miyamichi, L. Li, and L. Luo. 2007. A global double-fluorescent Cre reporter mouse. Genesis. 45:593-605. http://dx.doi.org/10.1002/dvg.20335
48. Nandi, S., S. Gokhan, X.M. Dai, S. Wei, G. Enikolopov, H. Lin, M.F. Mehler, and E.R. Stanley. 2012. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 367:100-113. http://dx.doi.org/10.1016/j.ydbio.2012.03.026
49. Nemunaitis, J., K. Shannon-Dorcy, F.R. Appelbaum, J. Meyers, A. Owens, R. Day, D. Ando, C. O'Neill, D. Buckner, and J. Singer. 1993. Longterm follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colonystimulating factor. Blood. 82:1422-1427.
50. Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune. 1997. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:313-319. http://dx.doi.org/10.1016/S0014-5793(97)00313-X
51. Pan, H., L. Zhu, Y. Deng, and J.W. Pollard. 2006. Microarray analysis of uterine epithelial gene expression during the implantation window in the mouse. Endocrinology. 147:4904-4916. http://dx.doi.org/10.1210/en.2006-0140
52. Penkowa, M., C. Poulsen, J. Carrasco, and J. Hidalgo. 2002. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment. Exp. Neurol. 176:308-321. http://dx.doi.org/10.1006/exnr.2002.7968
53. Pickford, F., E. Masliah, M. Britschgi, K. Lucin, R. Narasimhan, P.A. Jaeger, S. Small, B. Spencer, E. Rockenstein, B. Levine, and T. Wyss-Coray. 2008. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118:2190-2199.
54. Pixley, F.J., and E.R. Stanley. 2004. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14:628-638. http://dx.doi.org/10.1016/j.tcb.2004.09.016
55. Pont, F., A. Collet, and G. Lallement. 1995. Early and transient increase of rat hippocampal blood-brain barrier permeability to amino acids during kainic acid-induced seizures. Neurosci. Lett. 184:52-54. http://dx.doi.org/10.1016/0304-3940(94)11166-G
56. Raivich, G., S. Haas, A. Werner, M.A. Klein, C. Kloss, and G.W. Kreutzberg. 1998. Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J. Comp. Neurol. 395:342- 358. http://dx.doi.org/10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2
57. Ray, S., M. Britschgi, C. Herbert, Y. Takeda-Uchimura, A. Boxer, K. Blennow, L.F. Friedman, D.R. Galasko, M. Jutel, A. Karydas, et al. 2007. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13:1359-1362. http://dx.doi.org/10.1038/nm1653
58. Rockenstein, E., M. Mallory, M. Mante, A. Sisk, and E. Masliaha. 2001. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J. Neurosci. Res. 66: 573-582. http://dx.doi.org/10.1002/jnr.1247
59. Rothwell, V.M., and L.R. Rohrschneider. 1987. Murine c-fms cDNA: cloning, sequence analysis and retroviral expression. Oncogene Res. 1:311-324.
60. Ryan, G.R., X.M. Dai, M.G. Dominguez, W. Tong, F. Chuan, O. Chisholm, R.G. Russell, J.W. Pollard, and E.R. Stanley. 2001. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood. 98:74-84. http://dx.doi.org/10.1182/blood.V98.1.74
61. Saija, A., P. Princi, A. Pisani, G. Santoro, R. De Pasquale, M. Massi, and G. Costa. 1992. Blood-brain barrier dysfunctions following systemic injection of kainic acid in the rat. Life Sci. 51:467-477. http://dx.doi.org/10.1016/0024-3205(92)90023-I
62. Sawada, M., Y. Itoh, A. Suzumura, and T. Marunouchi. 1993. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci. Lett. 160:131-134. http://dx.doi.org/10.1016/0304-3940(93)90396-3
63. Sherr, C.J., C.W. Rettenmier, R. Sacca, M.F. Roussel, A.T. Look, and E.R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 41:665-676. http://dx.doi.org/10.1016/S0092-8674(85)80047-7
64. Sierra, A., A.C. Gottfried-Blackmore, B.S. McEwen, and K. Bulloch. 2007. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia. 55:412-424. http://dx.doi.org/10.1002/glia.20468
65. Srinivas, S., T. Watanabe, C.S. Lin, C.M. William, Y. Tanabe, T.M. Jessell, and F. Costantini. 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1:4. http://dx.doi.org/10.1186/1471-213X-1-4
66. Takeuchi, A., O. Miyaishi, K. Kiuchi, and K. Isobe. 2001. Macrophage colonystimulating factor is expressed in neuron and microglia after focal brain injury. J. Neurosci. Res. 65:38-44. http://dx.doi.org/10.1002/jnr.1125
67. Villeda, S.A., J. Luo, K.I. Mosher, B. Zou, M. Britschgi, G. Bieri, T.M. Stan, N. Fainberg, Z. Ding, A. Eggel, et al. 2011. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 477:90-94. http://dx.doi.org/10.1038/nature10357
68. Vincent, V.A., C.C. Robinson, D. Simsek, and G.M. Murphy. 2002. Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures. J. Neurochem. 82:1388- 1397. http://dx.doi.org/10.1046/j.1471-4159.2002.01087.x
69. Walton, M.R., and I. Dragunow. 2000. Is CREB a key to neuronal survival? Trends Neurosci. 23:48-53. http://dx.doi.org/10.1016/S0166-2236(99)01500-3
70. Wang, Y., O. Berezovska, and S. Fedoroff. 1999. Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice. J. Neurosci. Res. 57:616-632. http://dx.doi.org/10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E
71. Wang, Y., K.J. Szretter, W. Vermi, S. Gilfillan, C. Rossini, M. Cella, A.D. Barrow, M.S. Diamond, and M. Colonna. 2012. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13:753-760. http://dx.doi.org/10.1038/ni.2360
72. Wei, S., S. Nandi, V. Chitu, Y.G. Yeung, W. Yu, M. Huang, L.T. Williams, H. Lin, and E.R. Stanley. 2010. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 88:495-505. http://dx.doi.org/10.1189/jlb.1209822
73. Wiktor-Jedrzejczak, W., A. Bartocci, A.W. Ferrante Jr., A. Ahmed-Ansari, K.W. Sell, J.W. Pollard, and E.R. Stanley. 1990. Total absence of colonystimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA. 87:4828-4832. http://dx.doi.org/10.1073/pnas.87.12.4828
74. Wyss-Coray, T. 2006. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12:1005-1015.
75. Yang, T., J.K. Knowles, Q. Lu, H. Zhang, O. Arancio, L.A. Moore, T. Chang, Q. Wang, K. Andreasson, J. Rajadas, et al. 2008. Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. PLoS ONE. 3:e3604. http://dx.doi.org/10.1371/journal.pone.0003604
76. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L.D. Shultz, and S. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:442-444. http://dx.doi.org/10.1038/345442a0
77. Zhu, L., S. Ramboz, D. Hewitt, L. Boring, D.S. Grass, and A.F. Purchio. 2004. Non-invasive imaging of GFAP expression after neuronal damage in mice. Neurosci. Lett. 367:210-212. http://dx.doi.org/10.1016/j.neulet.2004.06.020